Literature DB >> 34379763

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.

Alfredo G Puing1, Stephanie Ho2, Paul Frankel3, Bernard Tegtmeier1, Abigail Martin1, Justine Ross2, Deepa Nanayakkara1, Jana Dickter1, Tyler Seto4, Ryotaro Nakamura5, Randy Taplitz1, Sanjeet Dadwal1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34379763      PMCID: PMC8385995          DOI: 10.1093/infdis/jiab406

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Authors:  Samuel M Rubinstein; Divaya Bhutani; Ryan C Lynch; Jeremy L Warner; Michael A Thompson; Chih-Yuan Hsu; Yu Shyr; Shailesh Advani; Ruben A Mesa; Sanjay Mishra; Daniel P Mundt; Dimpy P Shah; R Alejandro Sica; Keith E Stockerl-Goldstein; Catherine Stratton; Matthias Weiss; Alicia Beeghly-Fadiel; Melissa Accordino; Sarit E Assouline; Joy Awosika; Ziad Bakouny; Babar Bashir; Stephanie Berg; Mehmet Asim Bilen; Cecilia A Castellano; Jacob C Cogan; Devendra Kc; Christopher R Friese; Shilpa Gupta; Daniel Hausrath; Clara Hwang; Nathalie A Johnson; Monika Joshi; Anup Kasi; Elizabeth J Klein; Vadim S Koshkin; Nicole M Kuderer; Daniel H Kwon; Chris Labaki; Tahir Latif; Eric Lau; Xuanyi Li; Gary H Lyman; Rana R McKay; Gayathri Nagaraj; Amanda Nizam; Taylor K Nonato; Adam J Olszewski; Hyma V Polimera; Andrew J Portuguese; Matthew M Puc; Pedram Razavi; Rachel Rosovski; Andrew Schmidt; Sumit A Shah; Aditi Shastri; Christopher Su; Pallawi Torka; Trisha M Wise-Draper; Leyre Zubiri
Journal:  Blood Cancer Discov       Date:  2022-05-05

2.  Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies.

Authors:  Zachary A Yetmar; Ryan B Khodadadi; Maria Teresa Seville; Lisa Brumble; John C O'Horo; Ravindra Ganesh; Raymund R Razonable
Journal:  Open Forum Infect Dis       Date:  2022-04-14       Impact factor: 4.423

3.  Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.

Authors:  Barbora Weinbergerová; Ivo Demel; Benjamin Víšek; Jan Válka; Martin Čerňan; Pavel Jindra; Jan Novák; Lukáš Stejskal; Flóra Kovácsová; Tomáš Kabut; Tomáš Szotkowski; Roman Hájek; Pavel Žák; Petr Cetkovský; Zdeněk Král; Jiří Mayer
Journal:  Hematol Oncol       Date:  2022-02-17       Impact factor: 4.850

Review 4.  COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments.

Authors:  José Carlos Martínez; R Alejandro Sica; Keith Stockerl-Goldstein; Samuel M Rubinstein
Journal:  Acta Haematol       Date:  2022-02-08       Impact factor: 3.068

5.  Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.

Authors:  Simona Biscarini; Simone Villa; Camilla Genovese; Mara Tomasello; Anna Tonizzo; Marco Fava; Nathalie Iannotti; Matteo Bolis; Bianca Mariani; Antonia Grazia Valzano; Letizia Corinna Morlacchi; Francesca Donato; Giuseppe Castellano; Ramona Cassin; Maria Carrabba; Antonio Muscatello; Andrea Gori; Alessandra Bandera; Andrea Lombardi
Journal:  Biomedicines       Date:  2022-08-18

Review 6.  Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic.

Authors:  David J H Bian; Siham Sabri; Bassam S Abdulkarim
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.